Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,510 signal articles · 199 in last 24h · 116,773 total before filter · latest 42m ago
199last 24h
1705last 7d
280● bullish (7d)
150● bearish (7d)
205publishers
AllMacro318Earnings763M&A102Regulatory25Product16Analyst24
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
The Crown Keeps Switching Hands: Apple Inc. (AAPL) vs NVIDIA Corporation (NVDA)
Insider Monkey6d agoneutral
The Crown Keeps Switching Hands: Apple Inc. (AAPL) vs NVIDIA Corporation (NVDA)

Apple Inc. (NASDAQ:AAPL) and NVIDIA Corporation (NASDAQ:NVDA) have traded the title of world’s most valuable company more than once in the past two weeks. Apple first edged ahead on Friday, July 17, at $4.88 trillion versus Nvidia’s roughly $4.86 trillion after Nvidia shares fell 3.5%. Nvidia returned to the top spot, then lost it again […]

Investing.com6d agobullish
Who wins most in NVIDIA’s $500 billion private capital deal?

Investing.com -- NVIDIA’s deal to mobilize over $500 billion in third-party capital with Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs, and KKR reframes how AI factories are built and financed. By turning GPU compute into a standardized, investable asset class, NVIDIA addresses severe liquidity bottlenecks. However, the financial rewards and structural advantages flow to specific winners across the AI and financial ecosystems. 1. NVIDIA: Offloading Debt to Safeguard Free Cash Flow NVI

Okta (OKTA) Is Considered a Good Investment by Brokers: Is That True?
Zacks6d agoneutral
Okta (OKTA) Is Considered a Good Investment by Brokers: Is That True?

According to the average brokerage recommendation (ABR), one should invest in Okta (OKTA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Is Carnival (CCL) a Buy as Wall Street Analysts Look Optimistic?
Zacks6d agobullish
Is Carnival (CCL) a Buy as Wall Street Analysts Look Optimistic?

The average brokerage recommendation (ABR) for Carnival (CCL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Air taxi firm Joby acquires defense tech company for $500 million
Reuters6d agoneutral
Air taxi firm Joby acquires defense tech company for $500 million

Joby Aviation said on Tuesday it would buy defense technology ‌company Resonant Sciences for about $500 million, as ‌it looks to scale its business in a growing ​defense market. Electric vertical take-off and landing aircraft (eVTOL) companies are focusing more on the military market amid ramped-up defense spending driven by wars in ‌Ukraine and the ⁠Middle East. Here are some more details: • Shares of Santa Cruz, California-based Joby ⁠fell 6.5% in premarket trading.

A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?
24/7 Wall St.6d agoneutral
A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?

BioCryst just turned profitable, its HAE drug Orladeyo is minting cash, and a rival's blockbuster acquisition just put the whole rare-disease sector in play. So which pharma giant has the most to lose by letting someone else snap it up first?